2m 2m 2m 2m 2m 2m 2m
Revelatn Bio (REVB)
NASDAQ
$4.15-$0.21 (-4.82%)
Price as of Nov 12, 2026 7:56 AM EST- $17.4MMarket Cap
- -84.14%1-Year Change
- BiotechnologyIndustry
Revelatn Bio (REVB)
$4.15-$0.21 (-4.82%)
REVB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.36 | ||
Change | +$0.42 (+10.66%) | ||
Open | $3.92 | ||
High | $4.36 | ||
Low | $3.91 | ||
Previous Close | $3.94 | ||
Volume | 11,549 | ||
30-Day Average Volume | 24,262 | ||
1-Week Change | 5.88% | ||
1-Month Change | -18.03% | ||
1-Year Change | -84.14% | ||
3-Year Change | -99.98% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 4.0M | ||
Total Assets | $10.0M | ||
Market Cap | $17.4M | ||
Enterprise Value | $8.2M | ||
Period: QTR TTM FY | |||
Revenue | $68,063.00 | ||
Net Income | -$3.3M | ||
Free Cash Flow | -$2.4M | ||
EBIT | -$3.3M | ||
EBITDA | -$3.3M | ||
Net Working Capital | $6.9M | ||
EPS | -$41.44 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | 121 | ||
P/B | 2 | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 7 | ||
Last Split Date | 10/20/2026 | ||
Earnings & Revenue